Literature DB >> 1564405

Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections.

S H Gregory1, L K Barczynski, E J Wing.   

Abstract

It has been suggested that mononuclear phagocytes serve as the principal site of replication for a number of intracellular pathogens including Listeria monocytogenes. To determine the role of the tissue macrophages (Kupffer cells) in the proliferation of Listeria taken up in the liver, the hepatic cell populations were purified and the associated bacteria were quantified at periodic intervals postinfection. Here we report that the bulk of Listeria injected intravenously into nonimmune mice replicated within hepatocytes rather than Kupffer cells. Whereas a 200-fold increase in the number of hepatocyte-associated Listeria occurred during the first 3 days following infection, a relatively small (less than 2-fold) increase in number of Kupffer cell-associated Listeria was observed. The Listeria injected intravenously into immune animals, on the other hand, were eliminated rapidly from the hepatocyte as well as the Kupffer cell population. The latter findings suggest that uptake and elimination of pathogenic organisms by "non-professional phagocytes" in the liver (i.e., hepatocytes) may be an important effector mechanism in host defenses.

Entities:  

Mesh:

Year:  1992        PMID: 1564405     DOI: 10.1002/jlb.51.4.421

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  ClpC ATPase is required for cell adhesion and invasion of Listeria monocytogenes.

Authors:  S Nair; E Milohanic; P Berche
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 2.  From hot dogs to CD8+ T cells: Listeria monocytogenes.

Authors:  E J Wing; S H Gregory
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

3.  Differential inlA and inlB expression and interaction with human intestinal and liver cells by Listeria monocytogenes strains of different origins.

Authors:  Hadewig Werbrouck; Koen Grijspeerdt; Nadine Botteldoorn; Els Van Pamel; Nancy Rijpens; Jo Van Damme; Mieke Uyttendaele; Lieve Herman; Els Van Coillie
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 4.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

5.  Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection.

Authors:  M Kinoshita; N Kuranaga; A Matsumoto; S Ono; N Shinomiya; H Hiraide; S Seki
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

6.  Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture.

Authors:  Quang-Tam Nguyen; Seong-A Ju; Sang-Min Park; Sang-Chul Lee; Hideo Yagita; In Hee Lee; Byung-Sam Kim
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

7.  Elimination of resident macrophages from the livers and spleens of immune mice impairs acquired resistance against a secondary Listeria monocytogenes infection.

Authors:  J N Samsom; A Annema; P H Groeneveld; N van Rooijen; J A Langermans; R van Furth
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

8.  Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes.

Authors:  E R Jensen; A A Glass; W R Clark; E J Wing; J F Miller; S H Gregory
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line.

Authors:  G Szalay; J Hess; S H Kaufmann
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Listeria monocytogenes infects human endothelial cells by two distinct mechanisms.

Authors:  D A Drevets; R T Sawyer; T A Potter; P A Campbell
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.